Opportunities for Harold Hamm Diabetes Center members include funding awards and access to core facilities. A variety of funding awards are available to members to encourage the further development of their work. Award applications are evaluated on a competitive, peer-reviewed basis by the Harold Hamm Research Grants Committee and an External Review Panel. Additional awards, such as matching awards to other funding opportunities, will be announced if they become available.
The Harold Hamm Diabetes Center (HHDC) is pleased to announce pilot funding opportunities for 2022. The HHDC Pilot Program will consider funding seven types of proposals including Team Science proposals, Pre-Team Science proposals, Novel Pilot Projects, Novel Pilot Projects for Post-Docs, Bridge Funding, Equipment grants and a Travel Stipend. Based on a matching gift, the HHDC will award up to $1.6M to researchers to launch investigations for Diabetes research. These funds will be augmented with a collaboration with the Stephenson Cancer Center for projects specifically aimed specifically at collaboration between researchers in diabetes and cancer.
HHDC-SCC FUNDED PROGRAMS:
Applications that address the themes of the HHDC will be given higher priority. Each proposal must address one or more of the following themes that describe HHDC funding priorities:
Theme 1: Cancer and Diabetes. Proposals that aim to answer questions about the relationship surrounding obesity, diabetes, and cancer. Some examples include:
Theme 2: Diabetes and Aging across the lifespan. Proposals that aim to gain basic science and clinical knowledge on the inter-relationship of obesity, diabetes and aging across the lifespan. Some Examples include:
Theme 3: Pancreas and Beta Cell Function. The early stages of obesity/metabolic-related insulin resistance are characterized by hypersecretion of insulin but as the disease progresses, beta cell exhaustion results in insulin insufficiency. In patients with type 1 diabetes autoimmune destruction of insulin production capacity leads to exogenous insulin dependency. We encourage investigators interested in all aspects of pancreatic function in diabetes and associated conditions to submit their research proposals in this area. This includes studies that utilize pancreatic tissue samples, relevant cell culture and animal models, and human-based studies of in-vivo and ex-vivo pancreatic function.
Some examples in this domain include:
If your research could benefit from use of human pancreatic samples, please contact us about opportunities to acquire these tissues locally.
Covid-19 related proposals: Proposals studying Covid-19 are welcome if they are related to the HHDC mission, e.g. exploring the relationship between diabetes and Covid-19 presentation or outcomes, and there is a plan for follow-on studies by applying for extramural funding.
LETTER OF INTENT:
A Letter of intent due to
HHDCGrants@ouhsc.eduby
5PM February 7, 2022. Applications selected for full application submission will be notified
by February 15, 2022. The projected start date for the award will be July 1, 2022.
LOI due February 7, 2022, and must include:
FULL APPLICATION:
The sponsored programs grant routing form and completed application must
be received by ORA at least three business days prior to the
March 15, 2022 grant application deadline. You must submit an electronic routing form
using SOONERTRACKGRANTS (https://soonertrackgrants.ouhsc.edu). A copy of the application must be attached to the SoonerTrack ticket
or emailed for review to your Sponsored Program Administrator. Once the
review is complete, the Face Page of the grant application must be signed
by the ORA Official before the PI submits the final application to HHDC.
SUBMISSION OF FINAL APPLICATION
Send the final application by e-mail to
HHDCGrants@ouhsc.edu no later than 5 pm, Tuesday,
March 15, 2022. Please title the application attached to the e-mail: HHDC <Type of
Grant> Grant-[PI Last Name, First Name].
Please submit the application as a single file in pdf format. Failure to follow these steps could cause your application to be overlooked
and not reviewed by the HHDC Grants Review Committee.
PROGRAM APPLICATION AND GUIDELINES
All applications will follow the HHDC Application Form, Terms and Guidelines
found here:
HHDC Diabetes Programs:
HHDC-SCC Diabetes/Cancer Programs:
Questions
For questions or for special exception of the announcement approval, please contact Katie Hoefling at HHDCGrants@ouhsc.edu.
Researchers at Oklahoma Children’s Hospital OU Health are conducting a clinical research study to determine if children who have had concussions may ...
OU Health, Oklahoma’s only integrated, comprehensive academic health system, has named Jonathan W. Curtright, MBA, MHA, chief operations officer. ...
TSET Health Promotion Research Center at OU Health Stephenson Cancer Center and Freedom Oklahoma, a statewide LGBTQ2S+ serving organization, are ...